Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is extremely difficult to detect guanine nucleotide exchange or hydrolysis stimulated by receptors which couple to G(s)alpha. Furthermore, G(s)alpha is largely resistant to the GTPase-activating properties of
RGS
proteins. Coexpression of the
vasopressin
V(2) receptor with a series of chimeric G protein alpha subunits in which the C-terminal 6-12 amino acids of G(i1)alpha were replaced with the equivalent sequence of G(s)alpha allowed robust
vasopressin
-stimulated [(35)S]GTPgammaS binding. Vasopressin did not stimulate the GTPase activity of fusion proteins between the V(2) receptor and either G(s)alpha or G(i1)alpha. However, it produced a concentration-dependent stimulation of V(max) for a V(2) receptor-G(i1)alpha/Gs6alpha fusion protein. This construct bound [(3)H]
vasopressin
with high affinity and this was competed by other ligands with rank order anticipated for the V(2) receptor. RGS1 enhanced
vasopressin
stimulation of V(2) receptor-G(i1)alpha/G(s)6alpha in a concentration-dependent manner.
RGS
-GAIP was substantially less potent. Enzyme kinetic analysis demonstrated that RGS1 increased both V(max) of the GTPase activity and the observed K(m) for GTP, consistent with RGS1 accelerating the rate of GTP hydrolysis of the chimeric G protein, whereas the agonist
vasopressin
accelerates guanine nucleotide exchange. This approach provides a sensitive assay for V(2) receptor agonist ligands and may be amenable to many other G(s)alpha-coupled receptors.
...
PMID:Engineering a V(2) vasopressin receptor agonist- and regulator of G-protein-signaling-sensitive G protein. 1177 13
The antidiuretic effect of
vasopressin
is mediated by V2 receptors (V2R) that are located in kidney connecting tubules and collecting ducts. This study provides evidence that V2R signaling is negatively regulated by regulator of G protein signaling 2 (RGS2), a member of the family of
RGS
proteins. This study demonstrates that (1) RGS2 expression in the kidney is restricted to the
vasopressin
-sensitive part of the nephron (thick ascending limb, connecting tubule, and collecting duct); (2) expression of RGS2 is rapidly upregulated by
vasopressin
; (3) the
vasopressin
-dependent accumulation of cAMP, the principal messenger of V2R signaling, is significantly higher in collecting ducts that are microdissected from the RGS2(-/-) mice compared with their wild-type littermates; and (4) analysis of urine output of mice that were exposed to water restriction followed by acute water loading revealed that RGS2(-/-) mice exhibit an increased renal responsiveness to
vasopressin
. It is proposed that RGS2 is involved in negative feedback regulation of V2R signaling.
...
PMID:Increased renal responsiveness to vasopressin and enhanced V2 receptor signaling in RGS2-/- mice. 1747 20
Cascade-specific termination of G protein signaling is catalyzed by the
RGS
(regulator of G protein signaling) family members, including
RGS2
. Angiotensin,
vasopressin
, and endothelin are implicated in preeclampsia, and
RGS2
is known to inhibit G protein cascades activated by these hormones. Mutations in
RGS2
are associated with human hypertension and increased risk of developing preeclampsia and its sequelae.
RGS
family members are known to influence maternal vascular function, but the role of
RGS2
within the placenta has not been explored. Here, we hypothesized that reduced expression of
RGS2
within the placenta represents a risk factor for the development of preeclampsia. Although cAMP/CREB signaling was enriched in placentas from human pregnancies affected by preeclampsia compared with clinically matched controls and
RGS2
is known to be a CREB-responsive gene,
RGS2
mRNA was reduced in placentas from pregnancies affected by preeclampsia. Experimentally reducing
Rgs2
expression within the feto-placental unit was sufficient to induce preeclampsia-like phenotypes in pregnant wild-type C57BL/6J mice. Stimulation of
RGS2
transcription within immortalized human HTR8/SVneo trophoblasts by cAMP/CREB signaling was discovered to be dependent on the activity of histone deacetylase activity, and more specifically, HDAC9 (histone deacetylase-9), and
HDAC9
expression was reduced in placentas from human pregnancies affected by preeclampsia. We conclude that reduced expression of
RGS2
within the placenta may mechanistically contribute to preeclampsia. More generally, this work identifies
RGS2
as an
HDAC9
-dependent CREB-responsive gene, which may contribute to reduced
RGS2
expression in placenta during preeclampsia.
...
PMID:Reduced mRNA Expression of RGS2 (Regulator of G Protein Signaling-2) in the Placenta Is Associated With Human Preeclampsia and Sufficient to Cause Features of the Disorder in Mice. 3186 81